4Qian ZM,Li HY,Sun HZ,et al.Targeted drug delivery via the transfer-ring receptor mediated endocytosis pathway[J].Pharmacol Rev,2002,54(4):561-587.
5Daniels TR,Delgado T,Rodriguez JA,et al.The transferrin receptor partI:Biology and targeting with cytotoxic antibodies for the treatment of can-cer[J].Clin Dev Immunol,2006,121(2):144-158.
6Prutki M,Blazi MP,Jakopovic M,et al.Altered iron metabolism,trans-ferrin receptor1 and ferritin in patients with colon cancer[J].Cancer Lett,2006,238(2):188-196.
7Mastroberardino PG,Hoffman EK,Horowitz MP,et al.A novel transfer-rin/TfR2-mediated mitochondrial iron transport system is disrupted inParkinson’s disease[J].Neurobiol Dis,2009,34(3):417-431.
8Hemadi M,Kahn PH,Miquel G,et al.Transferrin’s mechanism of inter-action with receptor1[J].Biochemistry,2004,43(6):1 736-1 745.
9Ren W,Chang J,Yan C,et al.Development of transferrin functionalizedpoly(ethyleneglycol)/poly(lactic acid)amphiphilic block copolymericmicelles as a potential delivery system targeting brain glioma[J].J MaterSci:Mater Med,2010,21(9):2673-2681.
10Mulik RS,Monkkonen J,Juvonen RO,et al.Transferrin mediated solidlipid nanoparticles containing curcumin:Enhanced in vitro anticancer ac-tivity by induction of apoptosis[J].Int J Pharm,2010,398(1-2):190-203.
